These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6952273)

  • 1. Cardiac effects of prostaglandins during global ischemia in isolated perfused cat hearts.
    Okamatsu S; Lefer AM
    Prostaglandins Leukot Med; 1982 Jan; 8(1):1-10. PubMed ID: 6952273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prostaglandin D2 on isolated perfused guinea-pig hearts.
    Taube C; Förster W
    Acta Biol Med Ger; 1978; 37(5-6):773-5. PubMed ID: 742289
    [No Abstract]   [Full Text] [Related]  

  • 3. The protective effects of nifedipine in the isolated cat heart.
    Okamatsu S; Lefer AM
    J Surg Res; 1983 Jul; 35(1):35-40. PubMed ID: 6865391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart.
    Uemura S; Nakanishi T; Matsuoka S; Friedman WF; Jarmakani JM
    Pediatr Res; 1984 Dec; 18(12):1277-81. PubMed ID: 6596550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandins and their analogues on hormone-stimulated glycogenolysis in primary cultures of rat hepatocytes.
    Okumura T; Sago T; Saito K
    Biochim Biophys Acta; 1988 Feb; 958(2):179-87. PubMed ID: 3422165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Shimizu T; Hayashi O; Imura H
    Horm Metab Res; 1984 Dec; 16 Suppl 1():114-8. PubMed ID: 6152434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells.
    Sakai T; Yamaguchi N; Kawai K; Nishino H; Iwashima A
    Cancer Lett; 1983 Jan; 17(3):289-94. PubMed ID: 6572553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin actions and interactions on isolated perfused rat hearts.
    Karmazyn M; Leung CK; Dhalla NS
    Can J Physiol Pharmacol; 1979 Nov; 57(11):1275-82. PubMed ID: 391372
    [No Abstract]   [Full Text] [Related]  

  • 9. Early prostaglandin release from the ischemic myocardium in the dog.
    Ogletree ML; Flynn JT; Feola M; Lefer AM
    Surg Gynecol Obstet; 1977 May; 144(5):734-40. PubMed ID: 850857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose dependent stimulation by prostaglandin D2 of glucagon and insulin in perfused rat pancreas.
    Matsuyama T; Horie H; Namba M; Nonaka K; Tarui S
    Life Sci; 1983 Feb; 32(9):979-82. PubMed ID: 6338336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin-induced preservation of the ischemic myocardium.
    Ogletree ML; Lefer AM
    Circ Res; 1978 Feb; 42(2):218-24. PubMed ID: 620443
    [No Abstract]   [Full Text] [Related]  

  • 13. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release.
    Calabresi L; Rossoni G; Gomaraschi M; Sisto F; Berti F; Franceschini G
    Circ Res; 2003 Feb; 92(3):330-7. PubMed ID: 12595346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
    Nelson PK; Brookins J; Fisher JW
    J Pharmacol Exp Ther; 1983 Aug; 226(2):493-9. PubMed ID: 6410047
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prostaglandin E2 and D2 on gastric somatostatin and gastrin secretion.
    Takemura J; Seino Y; Nishi S; Ishida H; Sakita M; Taminato T; Chiba T; Imura H
    Regul Pept; 1983 Aug; 6(4):379-84. PubMed ID: 6138820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractoriness of diabetic platelets to inhibitory prostaglandins.
    Lagarde M; Berciaud P; Burtin M; Dechavanne M
    Prostaglandins Med; 1981 Oct; 7(4):341-7. PubMed ID: 6273957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
    Schrör K; Thiemermann C; Ney P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins and platelet aggregation.
    Smith JB
    Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The actions of prostaglandins and their interactions with angiotensin II in the isolated perfused human placental cotyledon.
    Glance DG; Elder MG; Myatt L
    Br J Obstet Gynaecol; 1986 May; 93(5):488-94. PubMed ID: 3518789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.